Biology, Genetics Healthcare, Pharma, Medical Device etc.
Category
Japan, United states of America, Rest of World
Geographic Coverage
Not Available
Video URL
Not Available
Sale price (USD)
Not Available
Non-exclusive license price (USD)
Not Available
Exclusive license price (USD)
Not Available
Non-exclusive license royalty rate %
Availability
Patent family
Number of members in the patent family
Assignee(s) / Patent owner(s)
To see the additional information details please login and subscribe to a Premium account.

Lipoid congenital adrenal hyperplasia

Patent Granted Lipoid congenital adrenal hyperplasia is an endocrine disorder that is an uncommon and potentially lethal form of congenital adrenal hyperplasia (CAH). It arises from defects in the earliest stages of adrenal cortisol synthesis: the transport of cholesterol into the mitochondria of the cells of the adrenal cortex and the conversion of cholesterol to pregnenolone—the first step in the synthesis of all steroid hormones. Lipoid CAH causes mineralocorticoid deficiency in affected infants and children. Male infants are severely undervirilized causing their external genitalia to look feminine. Consequently, they are usually raised as girls. The adrenals are large and filled with lipid globules derived from cholesterol.

GET LICENSE BROKER APPLY submit an inquiry
photo To see the additional information details please login and subscribe to a Plus or Premium account.